Effects of etanercept on quality of life, fatigue, and depression in psoriasis

The Lancet

Volume 367, Issue 9504, 7–13 January 2006, Pages 6-7

SR Feldman et al.
Etanercept improves the health-related quality of life of patients with psoriasis: results from a phase III randomized controlled trial
J Am Acad Dermatol
(2005)
J de Korte et al.
Quality of life in patients with psoriasis, a systematic literature review
J Invest Dermatol Symp Proc
(2004)
W-H Boehncke et al.
Leukocyte extravasation as a target for anti-inflammatory therapy–which molecule to choose?
Exp Dermatol
(2005)
JD Bos et al.
Psoriasis: activation of innate immunity
Br J Dermatol
(2005)
S Tyring et al.
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
Lancet
(2005)
W Sterry et al.
Biological therapies in the systemic management of psoriasis: International Consensus Conference
Br J Dermatol
(2004)

There are more references available in the full text version of this article.